Search results
Personalis CFO and COO Aaron Tachibana sells shares worth $9.3k By Investing.com
Investing.com· 4 days agoPersonalis, Inc. (NASDAQ:PSNL) reported that its Chief Financial Officer and Chief Operating...
There may be an increase in COVID cases this summer. Experts say this is why many shouldn't be...
ABC News· 6 days agoAs the United States heads into the summer season, early indicators show the country is likely to...
Sarepta’s Duchenne gene therapy wins expanded FDA approval - Boston Business Journal
The Business Journals· 4 days agoThe FDA has expanded its previous approval for Sarepta Therapeutics’ gene therapy to treat Duchenne...
FDA’s Sarepta decision could represent ‘new way of thinking’ for agency - Boston Business Journal
The Business Journals· 1 day agoThe U.S. Food and Drug Administration’s recent decision to expand approval for a Cambridge company’s controversial gene therapy could signal a changing approach to how the federal agency deals ...
The Issue Is: First TV sit-down with Independent VP candidate Nicole Shanahan
FOX 11 News Los Angeles· 4 days agoElex Michaelson goes one-on-one with Nicole Shanahan for her first TV sit-down since being named...
Roche, local startup Ascidian sign $1.8B deal for neurological medicines - Boston Business Journal
The Business Journals· 6 days agoAscidian Therapeutics has signed a deal with Roche in the Boston startup’s first-ever partnership....
Gateway - Quartz
Quartz· 6 days agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
Gateway - The Root
The Root· 7 days agoThe Biden administration is expected to announce this week that Americans who got the Pfizer-BioNTech or Moderna vaccines will need the third shot to protect themselves against ...
Gateway - Quartz
Quartz· 7 days agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, it has made its manufacturer an estimated ...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly - Eli Lilly and Co...
Benzinga· 3 days agoJune 21, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the...
